Literature DB >> 30316901

Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence.

Fawaz Alasmari1, Sunil Goodwani2, Robert E McCullumsmith3, Youssef Sari4.   

Abstract

Emerging evidence demonstrates that alcohol dependence is associated with dysregulation of several neurotransmitters. Alterations in dopamine, glutamate and gamma-aminobutyric acid release are linked to chronic alcohol exposure. The effects of alcohol on the glutamatergic system in the mesocorticolimbic areas have been investigated extensively. Several studies have demonstrated dysregulation in the glutamatergic systems in animal models exposed to alcohol. Alcohol exposure can lead to an increase in extracellular glutamate concentrations in mesocorticolimbic brain regions. In addition, alcohol exposure affects the expression and functions of several glutamate receptors and glutamate transporters in these brain regions. In this review, we discussed the effects of alcohol exposure on glutamate receptors, glutamate transporters and glutamate homeostasis in each area of the mesocorticolimbic system. In addition, we discussed the genetic aspect of alcohol associated with glutamate and reward circuitry. We also discussed the potential therapeutic role of glutamate receptors and glutamate transporters in each brain region for the treatment of alcohol dependence. Finally, we provided some limitations on targeting the glutamatergic system for potential therapeutic options for the treatment alcohol use disorders.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol dependence; Amygdala; Glutamate; Glutamate receptors; Glutamate transporters; Hippocampus; NAc; PFC; Striatum; VTA

Mesh:

Substances:

Year:  2018        PMID: 30316901      PMCID: PMC6261463          DOI: 10.1016/j.pneurobio.2018.10.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  280 in total

1.  Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior.

Authors:  Wei Zhu; Bihua Bie; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

2.  The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.

Authors:  Clyde W Hodge; Michael F Miles; Amanda C Sharko; Rebekah A Stevenson; Jennie R Hillmann; Veronique Lepoutre; Joyce Besheer; Jason P Schroeder
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

3.  Distribution of glutamate transporter subtypes during human brain development.

Authors:  O Bar-Peled; H Ben-Hur; A Biegon; Y Groner; S Dewhurst; A Furuta; J D Rothstein
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

4.  Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking.

Authors:  Daniel T Christian; Nancy J Alexander; Marvin R Diaz; Stacey Robinson; Brian A McCool
Journal:  Neuropharmacology       Date:  2012-02-22       Impact factor: 5.250

5.  Ethanol exposure decreases glutamate uptake in the nucleus accumbens.

Authors:  Roberto I Melendez; Megan P Hicks; Stephanie S Cagle; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

Review 6.  Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.

Authors:  Khaled Moussawi; Peter W Kalivas
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

7.  Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.

Authors:  Gunter Schumann; Monika Johann; Josef Frank; Ulrich Preuss; Norbert Dahmen; Manfred Laucht; Marcella Rietschel; Dan Rujescu; Anbarasu Lourdusamy; Toni-Kim Clarke; Kristina Krause; Anne Dyer; Martin Depner; Stefan Wellek; Jens Treutlein; Armin Szegedi; Ina Giegling; Sven Cichon; Dorothea Blomeyer; Andreas Heinz; Simon Heath; Mark Lathrop; Norbert Wodarz; Michael Soyka; Rainer Spanagel; Karl Mann
Journal:  Arch Gen Psychiatry       Date:  2008-07

8.  Hippocampal glutamate is increased and associated with risky drinking in young adults with major depression.

Authors:  Daniel F Hermens; Kate M Chitty; Rico Sc Lee; Ashleigh Tickell; Paul S Haber; Sharon L Naismith; Ian B Hickie; Jim Lagopoulos
Journal:  J Affect Disord       Date:  2015-07-26       Impact factor: 4.839

9.  GABA and glutamate overflow in the VTA and ventral pallidum of alcohol-preferring AA and alcohol-avoiding ANA rats after ethanol.

Authors:  Heidi Kemppainen; Noora Raivio; Harri Nurmi; Kalervo Kiianmaa
Journal:  Alcohol Alcohol       Date:  2010-01-13       Impact factor: 2.826

10.  Ethanol inhibits kainate responses of glutamate receptors expressed in Xenopus oocytes: role of calcium and protein kinase C.

Authors:  J E Dildy-Mayfield; R A Harris
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

View more
  20 in total

1.  Effects of datumetine on hippocampal NMDAR activity.

Authors:  Azeez Olakunle Ishola; Aminu Imam; Moyosore Salihu Ajao
Journal:  Toxicol Rep       Date:  2021-05-24

2.  Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.

Authors:  Silas A Buck; Mary M Torregrossa; Ryan W Logan; Zachary Freyberg
Journal:  FEBS J       Date:  2020-08-11       Impact factor: 5.542

Review 3.  A biological framework for emotional dysregulation in alcohol misuse: from gut to brain.

Authors:  Carina Carbia; Séverine Lannoy; Pierre Maurage; Eduardo López-Caneda; Kenneth J O'Riordan; Timothy G Dinan; John F Cryan
Journal:  Mol Psychiatry       Date:  2020-12-07       Impact factor: 15.992

4.  Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.

Authors:  Suchitra Krishnan-Sarin; Stephanie S O'Malley; Nicholas Franco; Dana A Cavallo; Jeanette M Tetrault; Julia Shi; Ralitza Gueorguieva; Brian Pittman; John H Krystal
Journal:  Neuropsychopharmacology       Date:  2019-10-07       Impact factor: 7.853

5.  Impaired synaptic transmission in dorsal dentate gyrus increases impulsive alcohol seeking.

Authors:  Maria Nalberczak-Skóra; Anna Beroun; Edyta Skonieczna; Anna Cały; Magdalena Ziółkowska; Roberto Pagano; Pegah Taheri; Katarzyna Kalita; Ahmad Salamian; Kasia Radwanska
Journal:  Neuropsychopharmacology       Date:  2022-10-01       Impact factor: 8.294

6.  Overexpression of wild type glycine alpha 1 subunit rescues ethanol sensitivity in accumbal receptors and reduces binge drinking in mice.

Authors:  Anibal Araya; Scarlet Gallegos; Adolfo Maldonado; Mario Rivera-Meza; Ramesh Chandra; Mary Kay Lobo; Luis G Aguayo
Journal:  Neuropsychopharmacology       Date:  2022-09-29       Impact factor: 8.294

7.  The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats.

Authors:  Colin N Haile; Benjamin A Carper; Tracy L Nolen; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2021-07-06       Impact factor: 4.530

8.  Aberrations in Incentive Learning and Responding to Heroin in Male Rats After Adolescent or Adult Chronic Binge-Like Alcohol Exposure.

Authors:  Ewa Galaj; Eddy Barrera; Debra Morris; Yao-Ying Ma; Robert Ranaldi
Journal:  Alcohol Clin Exp Res       Date:  2020-05-14       Impact factor: 3.455

9.  High Mobility Group Box 1/Toll-like Receptor 4 Signaling Increases GABRB3 Expression in Alcohol Exposure.

Authors:  Guangtao Sun; Xunzhong Qi; Wei Wang; Xintong Li; Chunhua Luo; Sunjie Bai; Shaohua Xu; Xiaogang Zhong; Chenglong Huang; Xiaofeng Zhu; Zuoyi Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-01       Impact factor: 2.570

Review 10.  Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease.

Authors:  Srijan Acharya; Kyeong-Man Kim
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.